Crossing barriers: the burden of inflammatory bowel disease across Western Europe
Aditi Kumar(National Childbirth Trust), Matthew Brookes(Wolverhampton Hospital), Gianluca Pellino(Universitat Autònoma de Barcelona), Vittoria Bellato(University of Rome Tor Vergata), Bram Verstockt(Universitair Ziekenhuis Leuven), A Marley(The Royal Wolverhampton NHS Trust), Mónica Millán(Universitat de València), Joana Roseira(Algarve Biomedical Center), Caterina Foppa(Humanitas University), Beatriz Gros(Western General Hospital), Alaa El‐Hussuna(Aalborg University Hospital), Dominik Bettenworth(University Hospital Münster), Miguel F Cunha, Nicolás Avellaneda(Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno), João A. Cunha Neves(Algarve Biomedical Center), Diane Mège(Aix-Marseille Université), Ignacio Catalán‐Serra(Norwegian University of Science and Technology), Nuha Yassin(University of Manchester), Pär Myrelid(Linköping University)
Cited by 35
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
|The Lancet|2020|1.8k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
|Journal of Crohn s and Colitis|2019|1.1k